Central Institute of Mental Health, Mannheim
77
10
13
46
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.7%
9 terminated/withdrawn out of 77 trials
83.6%
-2.9% vs industry average
10%
8 trials in Phase 3/4
2%
1 of 46 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (77)
PIONEERING XR TECHNOLOGY FOR THE PROMOTION OF RESILIENCE AND MENTAL HEALTH OF THE HEALTHCARE WORKFORCE
Role: collaborator
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Role: lead
Brain Signal Training to Enhance Affect Down-regulation
Role: lead
Enhancing Recovery in Early Schizophrenia
Role: lead
A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence
Role: lead
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
Role: lead
Substance Consumption, Personality, and Cognitive Functioning of Chess Players
Role: lead
Selective Attention in Alcohol Use Disorder
Role: lead
Chess Training as add-on Intervention for Adolescents With Psychiatric and Psychosomatic Disorders
Role: lead
Validation of a Training Program for Patients With Alcohol Use Disorder
Role: lead
Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder
Role: lead
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Role: lead
Electroconvulsive Therapy for Treatment of Alzheimer´s Disease
Role: lead
Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment
Role: lead
Evaluation Study of New Compounds With Potential Use in Schizophrenia
Role: lead
Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study
Role: lead
Increasing Smoking Cessation Success Through Sleep-amplified Memory Consolidation
Role: lead
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
Role: lead
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Role: lead
A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
Role: lead